Least surprising result ever. I await someone from Science Technology Studies to do a serious piece of work on the Vitamin D trials obsession @jonagar.bsky.social

JAMA@jama.com · 2d ago

In metastatic #ColorectalCancer, adding high-dose vitamin D3 to chemotherapy plus bevacizumab did not improve progression-free survival vs standard-dose vitamin D3. ja.ma/3RGAkMT

Just a reminder 2 weeks left to apply for these 4 Clinical Academic Training jobs @lshtm.bsky.social If applying for the Infection job do get in touch (leads for other posts on the adverts)

Michael Marks@drmichaelmarks.bsky.social · 3w ago

Academic clinical jobs @lshtm.bsky.social for people in UK clinical training Clinical Lecturers 1) Infectious Diseases (ST3-6) tinyurl.com/4vbjwrkr 2) Paediatrics (ST4-7) tinyurl.com/2hajhbs3 3) Public Health (ST3-5) tinyurl.com/yzd5cmxa Clinical Fellow in Primary Care (ST1) tinyurl.com/mpsmk7zk

📣 Opportunity for Clinical Scientists 🔬 The Rare and Imported Pathogens Laboratory (RIPL) are advertising a unique opportunity to join the highly specialist National clinical service. Join us to help shape and develop the future of the service! 🔗 Apply here: www.healthjobsuk.com/job/v8175970

Great opportunity with the great @rozeggo.bsky.social 100% endorsement.

LSHTM Alumni@lshtmalumni.bsky.social · last wk.

Applications are open for a three-year, full-time PhD studentship in modelling UK measles transmission. The project starts in January 2027 and is available to candidates eligible for the Home fee rate. Apply by 23 August 2026: www.lshtm.ac.uk/study/fees-a... @lshtm.bsky.social

Academic clinical jobs @lshtm.bsky.social for people in UK clinical training Clinical Lecturers 1) Infectious Diseases (ST3-6) tinyurl.com/4vbjwrkr 2) Paediatrics (ST4-7) tinyurl.com/2hajhbs3 3) Public Health (ST3-5) tinyurl.com/yzd5cmxa Clinical Fellow in Primary Care (ST1) tinyurl.com/mpsmk7zk

Delighted to see our special issue of Sexually Transmitted Diseases featuring a large number of outputs arising from the 2025 Shanghai International Syphilis Symposium & related work. Lots of great work & insights on the recent scientific progress. @typemat12.bsky.social @thelovetankcic.bsky.social

August 2026 - Volume 53 - Issue 8 : Sexually Transmitted Diseases

Discover the August 2026 issue of Sexually Transmitted Diseases, Volume 53, featuring peer-reviewed articles, case studies, and the latest research findings.

ovid.com

Led by @typemat12.bsky.social & with colleagues @thruzim.bsky.social @sangerinstitute.bsky.social & @lshtm.bsky.social our paper out now on using Amplicon-sequencing for genomic epidemiology of Syphilis in Africa.

Phylo-Plex: a phylogenetically informed, low-cost amplicon sequencing platform for deployable high-resolution genomic epidemiology - Nature Communications

Whole genome sequencing of pathogens is costly to implement, and partial sequencing sacrifices information. Here, the authors present Phylo-Plex, a method for identifying information-rich genomic regi...

nature.com

Recruiting a postdoc to join my lab at @lshtm.bsky.social to work in an MRC porgramme grant funded project to dissect the gut colonziation by Klebsiella. In vivo and in vitro models, and new approaches to identify Klebsiella factors involved. jobs.lshtm.ac.uk/vacancy.aspx...

Job Opportunity at LSHTM: Research Fellow

The London School of Hygiene & Tropical Medicine (LSHTM) is one of the world’s leading public health universities. Our mission is to improve health and health equity in the UK and worldwide; working i...

jobs.lshtm.ac.uk

That time of year again. Swedish Research Council peer review. Great fun last year on the Public Health & Epidemiology panel and a great range of projects BUT needing to read 40+ full proposals prior to the panel is a lot of work.

Bridget Freyne presenting CARES-1 trial: The first new trial for congenital syphilis treatment in 30 years & the first ever trial of a non-penicillin treatment for congenital syphilis. Super excited to be part of the team for this trial & looking forward to results over next 12-24 months.

Postdoc (London, UK) Modelling STI transmission in UK & evaluating impact of new interventions (DoxyPEP, testing, vaccines) with @drmichaelmarks.bsky.social at LSHTM More details: http://iddjobs.org/jobs/2556

Excited 1st SNAP result out @thelancet.com PSSA: Fluclox v BenPen thelancet.com/journals/lancet/article/PIIS0140-6736(26)00761-0/fulltext @nejm.org MSSA: Fluclox v Cefazolin nejm.org/doi/full/10.1056/NEJMoa2506905 Should change practice globally Privilege to help deliver trial with fantastic team

Come work @lshtm.bsky.social modelling STIs in UK & evaluation of new interventions. 3yr research fellow modelling post - feel free to get in touch to discuss. Current closing date 30th June @rozeggo.bsky.social @adamjkucharski.bsky.social @grahammedley.bsky.social @drlouisedyson.bsky.social

Job Opportunity at LSHTM: Research Fellow

The London School of Hygiene & Tropical Medicine (LSHTM) is one of the world’s leading public health universities. Our mission is to improve health and health equity in the UK and worldwide; working i...

jobs.lshtm.ac.uk

Very pleased the @who.int Programme Managers guide for control of scabies in low income settings now out. In many areas population prevalence of scabies is 10-30% making it a major public health problem. This guide is designed to assist Ministries of Health & NTD teams in scaling up interventions.

Special shout-out to Bridget Freyne @ucddublin.bsky.social (not on Bluesky) who is the CI for the trial & has done a large amount of the leg work getting this off the ground.

Michael Marks@drmichaelmarks.bsky.social · 3mo ago

Congratulations to @suhealthsci.bsky.social & Tygerberg Hospital for recruiting 1st patient into our trial of new therapies for infants with congenital syphilis! Huge effort across Ireland, UK, Malawi, South Africa, Indonesia, Thailand & Australia to get this off the ground. Trial details below.

Congratulations to @suhealthsci.bsky.social & Tygerberg Hospital for recruiting 1st patient into our trial of new therapies for infants with congenital syphilis! Huge effort across Ireland, UK, Malawi, South Africa, Indonesia, Thailand & Australia to get this off the ground. Trial details below.

Want to advance your #GlobalHealth career? With our Professional Diploma in Tropical Medicine & Hygiene you'll join doctors around the world & gain skills to diagnose, treat, & prevent diseases in limited resource settings. Runs in London 21 September-11 December 2026 👉 tinyurl.com/yrnbamhp

The @ukhsa.bsky.social DoxyPEP monitoring framework is now out. Grateful to have had the opportunity to contribute to this as part of my @nihr.bsky.social Professorship & looking forward to working with colleagues on these studies over the coming years.

Monitoring and evaluation plan of doxycycline post-exposure prophylaxis (doxyPEP)

gov.uk

Are you an LSHTM DTM&H Alumni? If so do sign up for our refresher course in July!

London School of Hygiene & Tropical Medicine@lshtm.bsky.social · 3mo ago

Refresh your tropical medicine knowledge with LSHTM’s DTM&H Refresher 9-10 July 2026 in London An update for DTM&H and MSc Tropical Medicine & International Health alumni, covering key developments in TB, HIV, malaria, child health & global health research. Apply by 11 June 2026 bit.ly/41I1Pal

Does anyone know why @orcid.org & @europepmc.org no longer have a functioning interface. Its gone from working fine, to broken, to removed entirely as an option and I can't see that @orcid.org have put anything out about this on their news page about this....

Project on developing ethnicity-stratified transmission models with me and Neil Ferguson. Please get in touch with any questions! Limited to home fees eligible students.

IDDjobs@iddjobs.org · 4mo ago

PhD position (London, UK) Modelling health inequalities in infectious disease transmission in the UK with @rozeggo.bsky.social and Neil Ferguson at @cmmid-lshtm.bsky.social More details: http://iddjobs.org/jobs/2525

Do you have a background in Health Economics and want to come and do a PhD on Syphilis and STI We have a funded studentship @lshtm.bsky.social. Come and collaborate with a great group of academics, clinicians and community groups Open to people eligible for UK PhD Fee Status - Apply by 11th May.

Great symposium @lshtm.bsky.social on 22nd April. Focused on analysis of social inequalities in transmission dynamics for infectious diseases. Can join online or in person (if coming in person please reach out to @rozeggo.bsky.social so we can make sure we have in-person capacity)

Clinical PhD opportunity @lshtm.bsky.social through @hpruezi.bsky.social Applications now close on 17th April. Ideal for UK Infection registrars wanting to do a PhD in clinical application of metagenomics in returning travellers. Collaboration with @emcat1.bsky.social & @ukhsa.bsky.social

NIHR Clinical Lectureship in Primary Care @lshtm.bsky.social Post is open to fully qualified GPs with a PhD and an academic track record. 4 Years of funding to develop your portfolio at one of the UKs leading Public Health and Primary Care research institutions. Apply by 13th April 2026.

Do you have a background in Health Economics and want to come and do a PhD on Syphilis and STI We have a funded studentship @lshtm.bsky.social. Come and collaborate with a great group of academics, clinicians and community groups Open to people eligible for UK PhD Fee Status - Apply by 11th May.

Really pleased to have contributed to the new @ukhsa.bsky.social Syphilis Action Plan and great to see this developed with a clear equity lens underpinning it. A lot work required by a wide range of stakeholders to meet the ambition of this plan over the coming years.

UKHSA Syphilis Response Plan

gov.uk

New Research Double-dose azithromycin mass drug administration, facial cleanliness, and fly control measures for trachoma control in Oromia, Ethiopia (Stronger SAFE): a cluster-randomised controlled trial www.thelancet.com/journals/lan...

Double-dose azithromycin mass drug administration, facial cleanliness, and fly control measures for trachoma control in Oromia, Ethiopia (Stronger SAFE): a cluster-randomised controlled trial

Enhanced A, F, and E (Stronger SAFE) had no additional effect compared with standard of care on reducing the prevalence of conjunctival C trachomatis at 3 years in this setting. It is therefore unlike...

thelancet.com

@lshtm.bsky.social launches its new MRes in Infectious & Tropical Diseases, a research-focused Master’s. It is based within LSHTM’s Faculty of Infectious & Tropical Disease. Strong option for intercaled students. More details here: www.lshtm.ac.uk/study/course...

MRes Infectious & Tropical Diseases | LSHTM

lshtm.ac.uk

For me the key take home from our recent work on African Syphilis genomics. Macrolide resistance now firmly established in South Africa & guidelines need to change & reflect this. Great collaboration with colleagues @sangerinstitute.bsky.social & in South Africa, Zimbabwe, Botswana, Uganda & Ghana.

Mat Beale@typemat12.bsky.social · 5mo ago

In South Africa, we observed a 10-year transition from macrolide sensitive local sublineages to imported macrolide resistant sublineages. These findings argue for removal of azithromycin from WHO treatment guidelines, and show the value of genomic surveillance.